JoshuaHillMD

Infectious Disease • Seattle, WA

Clinical Fellow in Medicine, Brigham and Women's Hospital

Join to view full profile

Dr. Hill is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hill's full profile

Already have an account?

Office
825 Eastlake Ave E
Seattle, WA 98109
Phone+1 617-496-5804

Education & Training

University of WashingtonFellowship, Infectious Disease, 2012 - 2015
UMass Chan Medical SchoolResidency, Surgery, 2002 - 2010
University of Texas Southwestern Medical SchoolClass of 2009

Certifications & Licensure

MT State Medical License 2022 - 2026
WA State Medical License 2013 - 2026
MA State Medical License 2011 - 2012

Clinical Trials

A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor Therapy Start of enrollment: 2021 Apr 28
Completed
Phase 2
Roles: Contact
Allogeneic Natural Killer (NK) Cell Therapy in Subjects Hospitalized for COVID-19 Start of enrollment: 2021 Aug 01
Completed
Phase 1
Roles: Contact, Principal Investigator
Vaccine Responsiveness After CAR-T Cell Therapy Start of enrollment: 2020 Aug 03
Recruiting
Phase 1
Roles: Contact, Principal Investigator

Publications & Presentations

PubMed

Chimeric antigen receptor-T-cell therapies going viral: latent and incidental viral infections.
Eleftheria Kampouri, Gemma Reynolds, Benjamin W Teh, Joshua A Hill
Current Opinion in Infectious Diseases. 2024-12-01
A systematic review and meta-analysis of HHV-6 and mortality after hematopoietic cell transplant.
Christopher J Stathis, Harrison Zhu, Kristen Carlin, Tuan L Phan, Danny Toomey
Bone Marrow Transplantation. 2024-12-01
1 citations
Understanding the Clinical Significance of Cytomegalovirus Viremia After Chimeric Antigen Receptor T-Cell Therapy: Should We be Treating a Value?
Eleftheria Kampouri, Michael J Boeckh, Joshua A Hill
Clinical Infectious Diseases. 2024-11-22

Press Mentions

What Does It Mean to Be Immunocompromised?December 12th, 2024
Infectious Disease Experts Propose Trials Network Dedicated to Immunocompromised PatientsOctober 24th, 2024
What Does It Mean to Be Immunocompromised?October 10th, 2024
Join now to see all